HPV 16/18 vaccines and the impact on organized cervical cancer screening REPLY

被引:0
|
作者
Sigurdsson, Kristjan [1 ]
机构
[1] Iceland Canc Soc, IS-101 Reykjavik, Iceland
关键词
D O I
10.3109/00016349.2010.487895
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:848 / 848
页数:1
相关论文
共 50 条
  • [1] Efficacy of HPV 16/18 vaccines on sexually active young women and the impact on organized cervical cancer screening
    Rossi, Paolo Giorgi
    Zorzi, Manuel
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2010, 89 (06) : 846 - 847
  • [2] The efficacy of HPV 16/18 vaccines on sexually active 18-23 year old women and the impact of HPV vaccination on organized cervical cancer screening
    Sigurdsson, Kristjan
    Sigvaldason, Helgi
    Gudmundsdottir, Thorbjorg
    Sigurdsson, Rafn
    Briem, Haraldur
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (01) : 27 - 35
  • [3] Modelling the impact of HPV vaccines on cervical cancer and screening programmes
    Garnett, Geoffrey P.
    Kim, Jane J.
    French, Katherine
    Goldie, Sue J.
    [J]. VACCINE, 2006, 24 : 178 - 186
  • [4] Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
    M Diaz
    J J Kim
    G Albero
    S de Sanjosé
    G Clifford
    F X Bosch
    S J Goldie
    [J]. British Journal of Cancer, 2008, 99 : 230 - 238
  • [5] Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
    Diaz, M.
    Kim, J. J.
    Albero, G.
    de Sanjose, S.
    Clifford, G.
    Bosch, F. X.
    Goldie, S. J.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 99 (02) : 230 - 238
  • [6] HPV16 and HPV18 genotyping in cervical cancer screening
    Ronco, Guglielmo
    Franceschi, Silvia
    Segnan, Nereo
    [J]. LANCET ONCOLOGY, 2011, 12 (09): : 831 - 832
  • [7] Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa
    Campos, Nicole G.
    Kim, Jane J.
    Castle, Philip E.
    Ortendahl, Jesse D.
    O'Shea, Meredith
    Diaz, Mireia
    Goldie, Sue J.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (11) : 2672 - 2684
  • [8] HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
    Kares, Saara
    Veijalainen, Olga
    Kholova, Ivana
    Tirkkonen, Mika
    Vuento, Risto
    Huhtala, Heini
    Tuimala, Veronica
    Maenpaa, Johanna
    Kujala, Paula
    [J]. APMIS, 2019, 127 (11) : 710 - 716
  • [9] IMPACT OF HPV 16 AND 18 ON INVASIVE CERVICAL CANCER SURVIVAL IN BRAZIL
    Genta, M. L. N. D.
    Anton, C.
    Sadalla, J. C.
    Carvalho, J. P. M.
    Levi, J. E.
    Oliveira, C.
    Carvalho, J. P.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 793 - 793
  • [10] Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
    Chua, Brandon Wen Bing
    Ma, Viva Yan
    Alcantar-Fernandez, Jonathan
    Wee, Hwee Lin
    [J]. INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2022, 67